echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > NAT MED: Antioxidant Key Protein Spromotes Relapse of Dormant Tumor Cells?

    NAT MED: Antioxidant Key Protein Spromotes Relapse of Dormant Tumor Cells?

    • Last Update: 2020-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Dormant tumor cells survive and relapse after treatment are the leading causes of death in cancer patientsPrevious studies have shown that the metabolic properties of these cells may differ from those of fast-growing tumor cellsrecently, researchers found that lowering Her2 in breast cancer cells promotes changes in cell metabolism, which eventually leads to an increase in oxidative stress and the compensation of the antioxidant transcription factor NRF2NRF2 is activated in dormant and recurrent tumors in animal models and breast cancer patients with poor prognosisThe constituent activation of NRF2 accelerates relapse, while inhibition of NRF2 reduces recurrencein recurrent tumors, NRF2 signalconduction induced transcription hyperbole reprogramming to reconstruct redox balance and boost deoxynucleotide synthesisNRF2-driven metabolic states make recurrent tumor cells sensitive to the inhibition of glutamine, preventing dormant tumor cells from being reactivated in vitro, suggesting that NRF2-high dormant and recurrent tumors may be targeted for treatmenttherefore, these data provide evidence that NRF2-driven metabolic reprogramming promotes the recurrence of dormant breast cancer
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.